Impact of US Hatch Waxman Act 1984
Reasons to Consider Joint Ventures
Becoming a Patent Lawyer
How Does the Knowledge Gap Worsen Over Time?
Rewards of the Practice
Post-Grant Options and Cost
Open Source Software
Cited Art Landscape
Patent Profile Analytics and Managers
Different Parts of a Patent Document
How is the Entire Patent Considered Prior Art?
Qualifying for a Patent
Is A United States Registered Trademark Effective in Other Countries?
Tracking Work History
Tools for Auditing a Patent Portfolio
What Does an Audit Action Sheet Look Like?
Domain Registration Considerations
Assessing Executive Experience
Refused Trademark Recourse
High Risk Joint Ventures
5 Year View Point
NDAs and Computer Codes
Post-Grant Options and Estoppel
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Is There Still a Place for Traditional Re-Examination?
Determining Likelihood of Confusion
NDAs and Customers
Engineers Not Understanding Patents
Forward Citation Landscape
Do Narrow Patents Add Value to a Portfolio?
Patent Trial and Appeal Board
Infringement on the Rights of Other Patents
Mitigating Risks of Past Damages
Low Risk Joint Ventures
Types of Inventions That Are Patentable
Common Law Trademark Rights
Researching Competitors' IP
Schwegman Lundberg & Woessner & Post Grant Trial Practice
PTAB Final Argument Trial Dynamics
Inter Partes Review
How to Fix the Knowledge Gap
Impact of Post-Grant Proceedings
What Do I Give up in Getting My Patent?
Broad Patent Claim
Types of Intellectual Property Protection
First Item on IP To-Do List
Ideal Patent Strategy
Helping In-House Council
Discovering Annuity Information
How do Patent Prosecution Services Vary in Value?
Considerations Before Hiring IP Council
What is a Patent?
What Makes Schwegman, Lundberg & Woessner Different?
What IP Should I Spend Money on First?
Trademarks and Brand Value
What to Do When First Selecting a Mark
Open Source Initiative
Unlicensed Source Codes
Consequences of Disclosing Confidential Information
Segmenting a Portfolio
Get Your Assignments Straight - Contribution of Owners
Are BioSimilars Being Approved in the US?
Forms of Confidential Information
Merely Descriptive Refusal
The Advantage of Filing First
Proper Way to Use a Trademark
BioSimilar Patenting Litigation Involving Large Amounts of Money
Cost/Value Curve of a High Level Patent
Scope Concepts and Headnotes
Geographic Insight and Patent Profile Analytics
Practicing an Invention
Importance of Getting a Patent
How Does the Knowledge Gap Develop?
Provisional vs Non-Provisional Patent
IP Registration Density
A Better Way to Allocate Patent Application Budgets
How Long Does an FTO Take?
Downside of Static Budget Allocation for Patents
Joint Venture Pitfalls
How Should IP be Considered for Acquisition?
Meet Mark Stignani
Value Management Lifecycle
A Less Expensive Alternative
Equal Value Patents
Prior Art in Prosecution vs Prior Art in Litigation
By the Numbers Overview
Freedom to Operate (FTO) Process
Freedom To Operate
Advantages of Registering a Trademark
How to Remedy Unwanted Disclosure of Confidential Information
Cost/Value Curve of Patent a Portfolio
Contractual Intellectual Property Rights
When to Do a Freedom to Operate
What Should a Company Understand at the End of an IP Audit?
Implementing a Value-Driven Portfolio Process
Patent Profile Analytics and Engineers
Should IP be Part of Our Business Plan?
Factors That Make a Patent Valuable
Raising Good Prosecution Visibility
Approvals of BioSimilars in Europe
Most Common Client Question
Value Management and Cash Flow
Independent Claim vs Dependent Claim
The Five Components of an Open Source Software Policy
What Engineers Can Learn from Patent Profile Analytics
Why Perform Risk Profile?
When is a House like a Patent?
Infringing on Another Patent
Date of First Use
Calculating New Investments
What is Prior Art?
What is a Trademark?
Post-Grant Options and Grounds of Challenge
"Whens" - Audit Action Sheet
Requirements to Receive a Patent
Why Is Executing an NDA Not Enough?
Cost of Registering a Trademark
Attorneys Not Understanding the Market
FDA Guidelines for Demonstrating Biosimilarity
Am I Required to Search for Prior Art?
Patent Ownership and Patent Profile Analytics
Improperly Marked Product
Repeating Competitor Audits
What Doesn't a Patent Provide?
What is a BioSimilar Product Under US Law?
Steps to Obtaining a Patent
"Who" - Audit Action Sheet
Picking a Domain Name
Patents and Other Forms of Intellectual Property Protection
Claim Abstraction Theory
Trade Name Protection and Trademark Protection
Risks of Not Patenting
Patent Examination Process
"Wheres" - Audit Action Sheet
Renewing a Trademark Registration
What Should a Company Patent?
Litigation and BioSimilar Patenting
"Whats" - Audit Action Sheet
Patent Strategy Considerations
Outside of Law
Demonstrating BioSimilarity Under U.S. Law
Budgeting for Drafting and Prosecution
Joint Venture Ground Rules
Attributes of a Good Patent
Using Product Association with IP Assets
Limited Valuable Patents in Technology Area
Joint Venture and Financial Agreements
Third Party Confidentiality
Marking a Product
Biologics Price Competition and Innovation Act
Audit Action Sheet
What is a BioSimilar?
Goal of a Value-Driven Patent Portfolio
Who Determines Substitution Factors?
OSS Licensing Conditions
Risks of OSS
Improving Patent Portfolio Value
Intellectual Property Protection
Signing an NDA
Rebutting a Merely Descriptive Refusal
How is Open Source Incorporated into Software?
Categories of Marks
First Step in Performing a Patent Portfolio Audit
Moderate Risk Joint Ventures
Claim Maps and BioSimilars
Joint Ventures and Dispute Resolution
Covered Business Method Review
How Big Should My First Patent Be?
Value Management and Risk Management
Why Should Claims Not Be Read on the Prior Art?
How can OSS Negatively Affect a Company?
"Claims" of a Patent
Picking a Trademark
Hiring Patent Council
Interpretational Differences Between Prosecution and Litigation
Golden Rule of Auditing a Patent Portfolio
Trademark Filing Considerations
How Much Does it Cost to Get a Patent?
Value-Driven Patent Portfolio
How Should IP be Considered for Growth?
Important Attributes to Being a Successful Patent Lawyer
Evaluation Agreement and Computer Codes
Patent Profile Analytics and Researchers
Standard for Getting a Patent
Trade Names vs Trademarks
Factors That Cause a Patent to Decline in Value
The Case of the Joint Marketing Agreement Gone Bad
Patents and Practicing an Invention
Impact of PTAB
Prior Art and Rejections
4 Ways to Prepare your Patent Portfolio for Battle.
How Do Patent Portfolio Values Become Concentrated over Time?
Portfolio Dashboard - Inventor Information
Patent Owner Rights
How is Schwegman Lundberg & Woessner Different?
Inventorship vs Ownership
Wasting Money on Low-Value Patents
Process for Registering a Trademark in the United States
Effective Stay Strategy
Intent of Patent Laws
Why Are Biologicals so Important?
Seeking Money from Investors
Two Main Value Drivers
"How Much" - Audit Action Sheet
Why Do You Enjoy Being a Lawyer?
Common Reasons Trademarks Are Rejected
Patent Analytics and Competition
How to Navigate BioSimilar Challenges
Meet David Black
Importance of Freedom To Operate
Purposes of a Trademark
The Different Types of Marks
Patent Status Updates
Auction Audit Sheet - Key Issues to Address
Secondary Meaning of a Trademark
Prior Art Challenge
Benefits of Audit Action Sheet
Freedom To Operate vs Clearance
Post-Grant Proceedings and Patent Enforcement
Freedom to Operate
Challenges When Dealing with Patent Matters
Attorneys and Patent Profile Analytics
How is Open Source Software Enforced?
Consequences of a Poorly Drafted Patent
What is a Patent Portfolio?
Inventors and Patent Analytics
Naming Problems with BioSimilars
Limiting Issues Defined in District Court
What is an Invention?
Confidential Information and Business Damage
Patent Portfolio and Budgets/Spending
Biologics vs Small Molecules
PTAB Timing Trial Dynamics
Importance of Post-Grant Proceedings
Patent Citation Ranking